Trial NCT03709706

View at ClinicalTrials.gov 
Org. Study IDs: 208471

Last trial update was posted on 2024-02-23

MeSH Interventions

Pembrolizumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Neoplasms

Stopping Reasons

The study was terminated for reasons pertaining to feasibility

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID